Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Pfizer
With
Astellas Pharma Inc
Medivation LLC, a wholly owned subsidiary of Pfizer Inc.
Age
18–any
Sex
MALE
Healthy volunteers
Not accepted
You may be eligible if
Men with metastatic castration-resistant prostate cancer
Progressive disease on androgen deprivation therapy
Patients must agree to continue androgen deprivation therapy with a GnRH agonist/antagonist throughout the study or have had a prior bilateral orchiectomy
ECOG performance score ≤ 1
Estimated life expectancy of ≥ 12 months
You may not be if
Prior cytotoxic chemotherapy, aminoglutethimide, ketoconazole, abiraterone, or enzalutamide for the treatment of prostate cancer
Prior participation in a clinical trial of an investigational agent that inhibits the androgen receptor or androgen synthesis (unless the treatment was placebo)
History of brain metastasis, active leptomeningeal disease or seizure
